Raymond James Financial Inc Haemonetics Corp Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 243,364 shares of HAE stock, worth $15.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
243,364Holding current value
$15.3 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
334Shares Held
54.2MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$375 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$326 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$280 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$265 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$254 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.23B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...